Recursion Pharmaceuticals Inc (RXRX)
5.695
-0.06
(-0.96%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.06
(+0.97%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Assets (Quarterly): 726.50M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 726.50M |
| June 30, 2024 | 775.86M |
| March 31, 2024 | 557.85M |
| December 31, 2023 | 653.70M |
| September 30, 2023 | 630.82M |
| June 30, 2023 | 666.70M |
| March 31, 2023 | 627.37M |
| December 31, 2022 | 701.29M |
| Date | Value |
|---|---|
| September 30, 2022 | 611.53M |
| June 30, 2022 | 672.52M |
| March 31, 2022 | 734.32M |
| December 31, 2021 | 610.34M |
| September 30, 2021 | 658.61M |
| June 30, 2021 | 698.59M |
| March 31, 2021 | 271.94M |
| December 31, 2020 | 298.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
271.94M
Minimum
Mar 2021
775.86M
Maximum
Jun 2024
618.53M
Average
656.15M
Median
Total Assets (Quarterly) Benchmarks
| Revance Therapeutics Inc | 461.56M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 201.94M |
| Shareholders Equity (Quarterly) | 524.56M |
| Debt to Equity Ratio | 0.0548 |
| Current Ratio | 4.355 |
| Net Debt Paydown Yield | -0.29% |